Adlyxine (lixisenatide)

pCPA File Number: 21005
Negotiation Status:
Concluded with an LOI
Indication(s):
Diabetes Mellitus, Type 2
Sponsor/Manufacturer:
Sanofi-Aventis Canada Inc.
CDA-AMC Project Number:
SR0520-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: